Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Aura Biosciences Inc has a consensus price target of $22.8 based on the ratings of 5 analysts. The high is $25 issued by HC Wainwright & Co. on March 25, 2025. The low is $19 issued by Citizens Capital Markets on March 26, 2025. The 3 most-recent analyst ratings were released by Citizens Capital Markets, HC Wainwright & Co., and HC Wainwright & Co. on March 26, 2025, March 25, 2025, and March 24, 2025, respectively. With an average price target of $22 between Citizens Capital Markets, HC Wainwright & Co., and HC Wainwright & Co., there's an implied 252.56% upside for Aura Biosciences Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
03/26/2025 | Buy Now | 204.49% | Citizens Capital Markets | Jonathan Wolleben65% | $21 → $19 | Maintains | Market Outperform | Get Alert |
03/25/2025 | Buy Now | 300.64% | HC Wainwright & Co. | Edward White52% | $22 → $25 | Maintains | Buy | Get Alert |
03/24/2025 | Buy Now | 252.56% | HC Wainwright & Co. | Edward White52% | $22 → $22 | Reiterates | Buy → Buy | Get Alert |
11/14/2024 | Buy Now | 252.56% | HC Wainwright & Co. | Edward White52% | $22 → $22 | Reiterates | Buy → Buy | Get Alert |
10/18/2024 | Buy Now | 268.59% | Scotiabank | George Farmer46% | $20 → $23 | Maintains | Sector Outperform | Get Alert |
10/18/2024 | Buy Now | 284.62% | BTIG | Robert Hazlett37% | $21 → $24 | Maintains | Buy | Get Alert |
10/18/2024 | Buy Now | 252.56% | HC Wainwright & Co. | Edward White52% | $21 → $22 | Maintains | Buy | Get Alert |
09/13/2024 | Buy Now | 268.59% | JMP Securities | Jonathan Wolleben65% | $19 → $23 | Maintains | Market Outperform | Get Alert |
09/13/2024 | Buy Now | 236.54% | HC Wainwright & Co. | Edward White52% | $21 → $21 | Reiterates | Buy → Buy | Get Alert |
08/28/2024 | Buy Now | 204.49% | JMP Securities | Jonathan Wolleben65% | $19 → $19 | Reiterates | Market Outperform → Market Outperform | Get Alert |
07/25/2024 | Buy Now | 236.54% | HC Wainwright & Co. | Edward White52% | → $21 | Initiates | → Buy | Get Alert |
12/08/2023 | Buy Now | 236.54% | BTIG | Robert Hazlett37% | $38 → $21 | Maintains | Buy | Get Alert |
11/10/2023 | Buy Now | 204.49% | JMP Securities | Jonathan Wolleben65% | $21 → $19 | Maintains | Market Outperform | Get Alert |
07/27/2023 | Buy Now | 268.59% | Scotiabank | George Farmer46% | → $23 | Initiates | → Sector Outperform | Get Alert |
03/16/2023 | Buy Now | 300.64% | JMP Securities | Jonathan Wolleben65% | $30 → $25 | Maintains | Outperform | Get Alert |
11/11/2022 | Buy Now | 380.77% | JMP Securities | Jonathan Wolleben65% | $26 → $30 | Maintains | Market Outperform | Get Alert |
07/19/2022 | Buy Now | 316.67% | JMP Securities | Jonathan Wolleben65% | → $26 | Initiates | → Market Outperform | Get Alert |
The latest price target for Aura Biosciences (NASDAQ:AURA) was reported by Citizens Capital Markets on March 26, 2025. The analyst firm set a price target for $19.00 expecting AURA to rise to within 12 months (a possible 204.49% upside). 11 analyst firms have reported ratings in the last year.
The latest analyst rating for Aura Biosciences (NASDAQ:AURA) was provided by Citizens Capital Markets, and Aura Biosciences maintained their market outperform rating.
There is no last upgrade for Aura Biosciences
There is no last downgrade for Aura Biosciences.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Aura Biosciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Aura Biosciences was filed on March 26, 2025 so you should expect the next rating to be made available sometime around March 26, 2026.
While ratings are subjective and will change, the latest Aura Biosciences (AURA) rating was a maintained with a price target of $21.00 to $19.00. The current price Aura Biosciences (AURA) is trading at is $6.24, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.